<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[My Site 1]]></title><description><![CDATA[My Site 1]]></description><link>https://www.patellab-ucla.org/blog</link><generator>RSS for Node</generator><lastBuildDate>Thu, 27 Aug 2026 18:14:46 GMT</lastBuildDate><atom:link href="https://www.patellab-ucla.org/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells]]></title><description><![CDATA[Given the invasive nature of glioblastoma, tumor cells exist beyond the contrast-enhancing (CE) region targeted during treatment. However, areas of non-enhancing (NE) tumors are difficult to visualize and delineate from edematous tissue. Amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) is a pH-sensitive molecular magnetic resonance imaging technique that was evaluated in its ability to identify infiltrating NE tumors and prognosticate survival. Methods: In this...]]></description><link>https://www.patellab-ucla.org/post/ph-weighted-amine-chemical-exchange-saturation-transfer-echo-planar-imaging-visualizes-infiltrating</link><guid isPermaLink="false">6a7e3cff24b7499942a76707</guid><pubDate>Thu, 13 Aug 2026 21:55:09 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8f2089_cd53a7b90f52480ea331de1cfb8907dc~mv2.jpg/v1/fit/w_611,h_514,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>kunalpatel243</dc:creator></item><item><title><![CDATA[Flexible in-cavity MRI receiving coil for ultra-high-resolution imaging of the pituitary gland]]></title><description><![CDATA[The objective of this study was the preclinical design and construction of a flexible intrasphenoid coil aiming for submillimeter resolution of the human pituitary gland. Methods: Sphenoid sinus measurements determined coil design constraints for use in > 95% of adult patients. Temperature safety parameters were tested. The 2-cm-diameter coil prototype was positioned in the sphenoid sinus of cadaveric human heads utilizing the transnasal endoscopic approach that is used clinically....]]></description><link>https://www.patellab-ucla.org/post/flexible-in-cavity-mri-receiving-coil-for-ultra-high-resolution-imaging-of-the-pituitary-gland</link><guid isPermaLink="false">6a7e3c9dd791ff6850b5a1e1</guid><pubDate>Thu, 13 Aug 2026 21:53:04 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8f2089_3435c2aad07c446eba4945d73b83b3bb~mv2.jpg/v1/fit/w_1000,h_723,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>kunalpatel243</dc:creator></item><item><title><![CDATA[Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma]]></title><description><![CDATA[Non-enhancing (NE) infiltrating tumor cells beyond the contrast-enhancing (CE) bulk of tumor are potential propagators of recurrence after gross total resection of high-grade glioma. Methods: We leveraged single-nucleus RNA sequencing on 15 specimens from recurrent high-grade gliomas (n = 5) to compare prospectively identified biopsy specimens acquired from CE and NE regions. Additionally, 24 CE and 22 NE biopsies had immunohistochemical staining to validate RNA findings. Results: Tumor cells...]]></description><link>https://www.patellab-ucla.org/post/single-nucleus-expression-characterization-of-non-enhancing-region-of-recurrent-high-grade-glioma</link><guid isPermaLink="false">6a7e3aabcae5bb2ffa10afd0</guid><pubDate>Thu, 13 Aug 2026 21:44:36 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8f2089_3c5efee2fcf2408f992cdac551dc0b46~mv2.jpg/v1/fit/w_762,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>kunalpatel243</dc:creator></item><item><title><![CDATA[Metastatic secondary gliosarcoma: patient series]]></title><description><![CDATA[Gliosarcoma is a rare and highly malignant cancer of the central nervous system with the ability to metastasize. Secondary gliosarcoma, or the evolution of a spindle cell-predominant tumor after the diagnosis of a World Health Organization grade IV glioblastoma, has also been shown to metastasize. There is little information on metastatic secondary gliosarcoma. Observations: The authors present a series of 7 patients with previously diagnosed glioblastoma presenting with recurrent tumor and...]]></description><link>https://www.patellab-ucla.org/post/metastatic-secondary-gliosarcoma-patient-series</link><guid isPermaLink="false">6a7e339a9eafd9eb8e5a9f79</guid><pubDate>Thu, 13 Aug 2026 21:14:21 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8f2089_6f58d13d25424f44aad7b2676d84bd3d~mv2.jpg/v1/fit/w_700,h_605,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>kunalpatel243</dc:creator></item><item><title><![CDATA[Molecular characterization of benign intracranial glioependymal and arachnoid cysts suggest heterogeneous mechanisms of action]]></title><description><![CDATA[Benign-appearing intracranial cysts may become symptomatic due to mass effect and require surgical treatment. Mechanisms underlying cyst formation and growth remain poorly understood. This study identified 16 patients who underwent surgical treatment for benign intracranial cysts. Cyst wall pathologic samples (n = 8) were characterized as arachnoid or glioependymal cysts using H&#38;E and immunofluorescence staining. Five samples (62.5%) were found to be glioependymal while three (37.5%) were...]]></description><link>https://www.patellab-ucla.org/post/molecular-characterization-of-benign-intracranial-glioependymal-and-arachnoid-cysts-suggest-heteroge</link><guid isPermaLink="false">6a7e15376fa7acef5ced074a</guid><pubDate>Thu, 13 Aug 2026 19:04:45 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8f2089_cf58f4149dc74bfa8b83308fd14b5dac~mv2.jpg/v1/fit/w_633,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>kunalpatel243</dc:creator></item><item><title><![CDATA[Socioeconomic Factors Associate With Access but not Survival in Neurosurgical Brain Tumor Patients]]></title><description><![CDATA[Database studies have identified population-level differences in neurosurgical-oncological outcomes. This study aimed to clarify these distinctions by evaluating associations between patient sociodemographics and metrics of care access, utilization, and clinical outcomes. Methods: We retrospectively reviewed a prospectively identified database of neurosurgical-oncology patients (n = 1476) over 5 years. We conducted pathology-specific, multivariate analyses to identify sociodemographics...]]></description><link>https://www.patellab-ucla.org/post/socioeconomic-factors-associate-with-access-but-not-survival-in-neurosurgical-brain-tumor-patients</link><guid isPermaLink="false">6a7e12761edc2c80bd34cf5a</guid><pubDate>Thu, 13 Aug 2026 18:53:23 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8f2089_e9541f17ca994c4e8659095454950a2e~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>kunalpatel243</dc:creator></item><item><title><![CDATA[Choroid Plexus Cauterization Prevents Postoperative Hydrocephalus in Adult Glioblastoma Resection With Ventricular Entry]]></title><description><![CDATA[Glioblastoma often extends along the subventricular zone and resection frequently results in ventricular entry, which is associated with increased risk of postoperative hydrocephalus. Choroid plexus cauterization (CPC) is a treatment for pediatric hydrocephalus, but its utility in preventing postoperative hydrocephalus following glioblastoma resection with ventricular entry is unknown. We sought to characterize CPC safety and efficacy in preventing postoperative hydrocephalus in this setting....]]></description><link>https://www.patellab-ucla.org/post/choroid-plexus-cauterization-prevents-postoperative-hydrocephalus-in-adult-glioblastoma-resection-wi</link><guid isPermaLink="false">6a7e11109eafd9eb8e5a5905</guid><pubDate>Thu, 13 Aug 2026 18:50:07 GMT</pubDate><dc:creator>kunalpatel243</dc:creator></item><item><title><![CDATA[Supramaximal Resection in Glioblastoma: Expanding Surgical Boundaries in the Era of Precision Neuro-Oncology-A Systematic Review]]></title><description><![CDATA[Background: Glioblastoma remains the most aggressive and treatment-resistant primary brain tumor, with patient outcomes strongly associated with the extent of surgical resection. Tumor recurrence is largely driven by infiltrating glioma cells that extend beyond the contrast-enhancing margin, which has traditionally served as the boundary for surgical resection. Advances in pre- and intraoperative imaging, functional mapping, and fluorescence guidance have challenged the conventional...]]></description><link>https://www.patellab-ucla.org/post/supramaximal-resection-in-glioblastoma-expanding-surgical-boundaries-in-the-era-of-precision-neuro</link><guid isPermaLink="false">6a5536695d6cee77176d73d3</guid><pubDate>Mon, 13 Jul 2026 19:03:10 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/8f2089_03c3df2992fa45b68409f821a8fcc0a2~mv2.jpg/v1/fit/w_550,h_821,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>kunalpatel243</dc:creator></item></channel></rss>